Rawalpindi Institute Of Cardiology
Clinical trials sponsored by Rawalpindi Institute Of Cardiology, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a daily pill replace frequent blood tests for heart valve patients? Results expected Apr 2027 (estimated)
-
Heart surgery patients may get safer intubation with new drug combo
Symptom relief Recruiting nowThis study compares two medications, dexmedetomidine and lignocaine, given before placing a breathing tube in heart surgery patients. The goal is to see which drug better controls sudden rises in blood pressure and heart rate during the procedure. About 70 adults at risk for hear…
Phase 4 • Sponsor: Rawalpindi Institute of Cardiology • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Heart surgery pain drug showdown: which is safer?
Symptom relief Recruiting nowThis study compares two pain medicines, nalbuphine and fentanyl, in 98 adults having heart surgery with a heart-lung machine. The goal is to see which drug better controls heart rate and blood pressure during the procedure. Participants receive one of the two drugs, and their vit…
Phase 4 • Sponsor: Rawalpindi Institute of Cardiology • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC